Key facts
- Knowtex’s last known valuation is $20.0M (Oct 2022).
- It has raised $2.5M; the latest was Early Stage VC in Jan 2026.
- Notable investors include Y Combinator, Transpose Platform Management, Pioneer Fund, Soma Capital, MedTech Innovator — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for Knowtex
- ·The full record, as it builds
Funding rounds
No funding rounds for Knowtex are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Knowtex
Developer of a clinical workflow platform intended to automate clinical tasks. The company's platform leverages AI (artificial intelligence) and voice technology to capture conversations, analyze them to identify relevant medical information, and create detailed visit notes with billing code suggestions and order entry, enabling healthcare providers and medical institutions to reduce administrative burden and enhance operational efficiency.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2022
- Employees
- 6
- Website
- knowtex.ai/
- Ownership
- Privately Held (backing)
Knowtex doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Knowtex shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Knowtex in its N-PORT filings yet. We sweep new filings monthly.